Dr. Martens Plc (GB:DOCS) has released an update.
IngreGrsy Limited has acquired a 38.46% stake in Dr. Martens PLC, as part of a restructure within the Permira V Fund. The transaction, completed on June 12, 2024, sees IngreGrsy Limited taking over from IngreLux S.àr.l. as a major shareholder in the iconic British footwear brand. This significant move could potentially influence the future direction and control of the company.
For further insights into GB:DOCS stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
